Sabet A - Search Results

1

Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.

Wenzel M, Koll F, Hoeh B, Humke C, Reis H, Wild P, Steuber T, Graefen M, Tilki D, Sabet A, Gröner D, Chun FKH, Mandel P. Wenzel M, et al. Among authors: sabet a. JCO Precis Oncol. 2024 Dec;8:e2400645. doi: 10.1200/PO-24-00645. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642328

2

Real-World Comparison of Cabazitaxel Versus ¹⁷⁷Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer.

Wenzel M, Koll F, Hoeh B, Humke C, Siech C, Mader N, Sabet A, Groener D, Steuber T, Graefen M, Maurer T, Brandts C, Banek S, Chun FKH, Mandel P. Wenzel M, et al. Among authors: sabet a. J Nucl Med. 2025 Jan 3;66(1):61-66. doi: 10.2967/jnumed.124.268807. J Nucl Med. 2025. PMID: 39542702

3

Extended therapy with [¹⁷⁷Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer.

Mader N, Nguyen Ngoc C, Kirkgöze B, Baumgarten J, Groener D, Klimek K, Happel C, Tselis N, Chun FKH, Grünwald F, Sabet A. Mader N, et al. Among authors: sabet a. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1811-1821. doi: 10.1007/s00259-023-06119-1. Epub 2023 Jan 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 36702927 Free PMC article.

4

Hematologic safety of ¹⁷⁷Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.

Groener D, Nguyen CT, Baumgarten J, Bockisch B, Davis K, Happel C, Mader N, Nguyen Ngoc C, Wichert J, Banek S, Mandel P, Chun FKH, Tselis N, Grünwald F, Sabet A. Groener D, et al. Among authors: sabet a. EJNMMI Res. 2021 Jul 3;11(1):61. doi: 10.1186/s13550-021-00805-7. EJNMMI Res. 2021. PMID: 34216290 Free PMC article.

5

Salvage Radioligand Therapy with Repeated Cycles of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement.

Groener D, Baumgarten J, Haefele S, Happel C, Klimek K, Mader N, Nguyen Ngoc C, Tselis N, Chun FKH, Grünwald F, Sabet A. Groener D, et al. Among authors: sabet a. Cancers (Basel). 2021 Aug 10;13(16):4017. doi: 10.3390/cancers13164017. Cancers (Basel). 2021. PMID: 34439172 Free PMC article.

6

[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios].

Kranert WT, Bockisch B, Wichert J, Gröner D, Sabet A, Baumgarten J, Nguyen Ngoc LQC, Grünwald F, Happel C. Kranert WT, et al. Among authors: sabet a. Nuklearmedizin. 2022 Apr;61(2):111-119. doi: 10.1055/a-1697-8126. Epub 2022 Feb 15. Nuklearmedizin. 2022. PMID: 35170005 German.

7

Intermittent Radioligand Therapy with ¹⁷⁷Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.

Mader N, Schoeler C, Pezeshkpour N, Klimek K, Groener D, Happel C, Tselis N, Mandel P, Grünwald F, Sabet A. Mader N, et al. Among authors: sabet a. Cancers (Basel). 2023 Sep 17;15(18):4605. doi: 10.3390/cancers15184605. Cancers (Basel). 2023. PMID: 37760574 Free PMC article.

8

Impact of [¹⁷⁷Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [⁶⁸Ga]Ga-PSMA-11-PET/CT.

Groener D, Wichert J, Adams M, Mader N, Klimek K, Nguyen Ngoc C, Baumgarten J, Happel C, Mandel P, Chun FKH, Tselis N, Grünwald F, Sabet A. Groener D, et al. Among authors: sabet a. Cancers (Basel). 2023 Jul 30;15(15):3878. doi: 10.3390/cancers15153878. Cancers (Basel). 2023. PMID: 37568694 Free PMC article.

9

Safety and Efficacy of ¹⁷⁷Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing ²²³Radium-Dichloride.

Baumgarten J, Groener D, Nguyen Ngoc C, Mader N, Chaurasia M, Davis K, Wichert J, Chun FKH, Tselis N, Happel C, Grünwald F, Sabet A. Baumgarten J, et al. Among authors: sabet a. Cancers (Basel). 2022 Jan 22;14(3):557. doi: 10.3390/cancers14030557. Cancers (Basel). 2022. PMID: 35158825 Free PMC article.

10

[Radiofrequency ablation of benign thyroid nodules].

Grünwald F, Baumgarten J, Happel C, Sabet A, Gröner D. Grünwald F, et al. Among authors: sabet a. Laryngorhinootologie. 2022 Jul;101(7):569-573. doi: 10.1055/a-1057-3222. Epub 2022 Jun 23. Laryngorhinootologie. 2022. PMID: 35738271 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters